Fetal parvovirus B19 infection

Ultrasound in Obstetrics and Gynecology

Volumn 18, Issue 3, 2001, Pages 280-288

  Von Kaisenberg, C S ^a   Jonat, W ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

Anemia; Ascites; Cardiomegaly; Cordocentesis; Fetus; Hepatomegaly; Infection; Intrauterine therapy; Intrauterine transfusion; Parvovirus B19; Pericardial effusions; Pleural effusions; Splenomegaly

Indexed keywords

ADULT; AMNION FLUID ANALYSIS; ANEMIA; CELL MATURATION; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DOPPLER ECHOGRAPHY; ELECTRON MICROSCOPY; FEMALE; FETUS; FETUS BLOOD; HUMAN; HYDROPS; INTRAUTERINE BLOOD TRANSFUSION; INTRAUTERINE INFECTION; MAJOR CLINICAL STUDY; MYOCARDITIS; PARVOVIRUS; POLYMERASE CHAIN REACTION; PREGNANCY; PRIORITY JOURNAL; REVIEW;

FEMALE; FETAL DISEASES; HUMANS; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; PREGNANCY;

EID: 0034821947     PISSN: 09607692     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1469-0705.2001.00471.x     Document Type: Review

References (83)

1. Human parvovirus B19 and its associated diseases
2. B19 human parvovirus in pregnancy
3. Parvovirus B19 infection in pregnancy
4. Cordocentesis for the diagnosis and treatment of human fetal parvovirus infection
5. Long-term outcome in fetal hydrops from parvovirus B19 infection
6. Diagnosis of fetal infection in the patient with an ultrasonographically detected abnormality but a negative clinical history
7. Parvovirus infection in pregnancy
8. A case of fetal parvovirus B19 myocarditis, terminal cardiac heart failure, and perinatal heart transplantation
9. Age specific antibody prevalence to parvovirus B19: How many women are infected in pregnancy?
10. Parvovirus infection of the human fetus and newborn
11. Parvovirus B19 infections in pregnancy
12. Risk of infection following exposures to human parvovirus B19
13. Prospective evaluation of 618 pregnant women exposed to parvovirus B19: Risks and symptoms
14. A prospective study of antibodies against parvovirus B19 in pregnancy
15. The incidence of human parvovirus B19 infection during pregnancy and its impact on perinatal outcome
16. Risk factors for parvovirus B19 infection in pregnancy
17. Parvovirus B19 infection and hematopoiesis
18. Immunological approach of anti-H (9), anti-Lewis (6), anti-P (3) and anti-Pr (1) monoclonal antibodies
19. Parvoviruses and bone marrow failure
20. Fetal damage caused by parvoviral infections
21. Parvovirus B19 and pediatric pathology
22. Fetal hydrops in the first trimester associated with maternal parvovirus infection
23. A case of early intra-uterine parvovirus B19 infection
24. Intra-uterine parvovirus B19 infection and meconium peritonitis
25. Fetal parvovirus B19 infection and meconium peritonitis
26. Severe Shwachman-Diamond syndrome and invasive parvovirus B19 infection
27. Parvovirus B19 infection in a twin pregnancy
28. Comparative evaluation of virological and serological methods in prenatal diagnosis of parvovirus B19 fetal hydrops
29. Prenatal diagnosis of congenital parvovirus B19 infection: Value of serological and PCR techniques in maternal and fetal serum
30. Clinical and epidemiological study of human parvovirus B19 infection in fetal hydrops using PCR Southern blot hybridization and chemiluminescence detection
31. Prenatal diagnosis of human parvovirus B19 in nonimmune hydrops fetalis by polymerase chain reaction
32. Maternal serum alpha-fetoprotein - A marker of fetal aplastic crisis during intrauterine human parvovirus infection
33. Seroprevalence of parvovirus B19 NS1-specific IgG in B19-infected and uninfected individuals and in infected pregnant women
34. Parvovirus particles in a fetal-heart with myocarditis: Ultrastructural and immunohistochemical study
35. Diagnosis and incidence of fetal parvovirus infection in an autopsy series. II. DNA Amplification
36. Laboratory diagnosis of parvovirus B19 infection: Comparison of ten commercial IgG- and IgM-antibody tests
37. Prediction of fetal anemia with Doppler measurement of the middle cerebral artery peak systolic velocity in pregnancies complicated by maternal blood group alloimmunization or parvovirus B19 infection
38. Fetal haemoglobin measurement in the assessment of red cell isoimmunisation
39. The relationship of fetal protein concentration and hemoglobin level to the development of hydrops in rhesus isoimmunization
40. Relationship of fetal hemoglobin and oxygen content to lactate concentration in Rh isoimmunized pregnancies
41. A comparison of sheep and human fetal oxygen delivery systems with use of a mathematical model
42. Doppler examination of the middle cerebral artery in anemic fetuses
43. Non-invasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red-cell alloimmunization
44. Management of parvovirus infection in pregnancy and outcomes of hydrops: A survey of members of the Society of Perinatal Obstetricians
45. Parvovirus B19 associated neutropenia. Treatment with Rh G-CSF
46. Aplastic crisis caused by Parvovirus B-19. Response to treatment with low doses of gammaglobulin
47. Fetal parvovirus B19 infection and liver disease of antenatal onset in an infant with Ebstein's anomaly
48. Human parvovirus infection in pregnancy and hydrops fetalis
49. Fetal infection with human parvovirus B19
50. Molecular biological demonstration of parvovirus infection in fetal tissue
51. Nonimmunologic hydrops fetalis resulting from intrauterine human parvovirus B-19 infection: Report of two cases
52. Parvovirus B19 infection of the fetus. Histology and in situ hybridization
53. An association between fetal parvovirus B19 infection and fetal anomalies: A report of two cases
54. Diagnosis and incidence of fetal parvovirus infection in an autopsy series I. Histology
55. Cardiac involvement in fetal parvovirus B19 infection
56. Parvovirus as a cause of hydrops fetalis: Detection by in situ DNA hybridisation
57. A fetus with a parvovirus B19 infection and congenital anomalies
58. Human parvovirus infection in pregnancy
59. Elevated maternal serum alpha-fetoprotein and hydrops fetalis in association with fetal parvovirus B-19 infection
60. Prenatal diagnosis of intrauterine infection with Parovirus B19 by the polymerase chain reaction technique
61. A rapid and safe method to detect fetal parvovirus B19 infection in amniotic fluid by polymerase chain reaction: Report of a case
62. Intrauterine blood transfusion for non-immune hydrops fetalis due to parvovirus B19 infection
63. Intrauterine transfusion treatment of nonimmune hydrops fetalis secondary to human parvovirus B19 infection
64. Fetoneonatal hydrops from human parvovirus B19
65. Management of fetal hydrops associated with parvovirus B19 infection
66. The causes and natural history of fetal ascites
67. Observational study of effect of intrauterine transfusions on outcome of fetal hydrops after parvovirus B19 infection
68. Human parvovirus B19 infection associated with hydrops fetalis
69. Late onset of hydrops fetalis following intrauterine parvovirus B19 infection
70. Resolution of human parvovirus B19-induced nonimmune hydrops after intrauterine transfusion
71. Intrauterine management of fetal parvovirus B19 infection
72. Hydrops fetalis caused by intrauterine human parvovirus infection
73. Parvovirus infection in pregnancy
74. Successful intrauterine treatment of fetal hydrops caused by parvovirus B19 infection
75. Severe nonimmune hydrops secondary to parvovirus B-19 infection: Spontaneous reversal in utero and survival of a term infant
76. Parvovirus B19 infection and transient fetal hydrops
77. Spontaneous resolution of nonimmune hydrops fetalis secondary to human parvovirus B19 infection
78. Fetal survival after human parvovirus B19 infection: Spectrum of intrauterine response in a twin gestation
79. Clinical significance of human parvovirus B19 infection in pregnancy
80. Spontaneous resolution of non-immune hydrops fetalis secondary to transplacental parvovirus B19 infection
81. Fetal hydrops secondary to human parvovirus infection in early pregnancy
82. Nonimmune hydrops fetalis caused by intrauterine human parvovirus B19 infection: A case of spontaneous reversal in utero
83. Acute parvovirus myocarditis with fatal outcome